Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles (Direct Biologics)

N/A

Report date: 2026/05/22 20:01:29

Base Information

Drug NameBone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles (Direct Biologics)
Drug Alias NameExoFloDB-001DB001DB-2Q
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Perianal fistulaHypoxia +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDirect Biologics Llc
China Registration ClassN/A

Develop Information

Active CompaniesDirect Biologics Llc
Inactive CompaniesN/A
Active IndicationsHypoxiaLow Back PainCytokine Release Syndrome +[4] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Perianal fistulaDyspnea +[7] 

Other Information

ATC CodeN/A
Related LinksN/A